Psychiatry Flashcards

(94 cards)

0
Q

Opioids

A

Intoxication: euphoria, respiratory and CNS depression, decreased gag reflex, pupillary constriction, seizures

Treatment: naloxone, naltrexone

Withdrawal: sweating, dilated pupils, lacrimation, piloerection, fever, rhinorrhea, yawning, nausea, stomach cramps, diarrhea

Treatment: long term suppport, mehodone, buprenoprhine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Benzodiazepines

A

Intoxification: greater safety margin. Ataxia, minor respiratory depression.

Treatment: supportive care, consider flumazenil

Withdrawal: sleep disturbance, depression, rebound anxiety, seizure, tachycardia palpitations, psychosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Caffeine

A

Intoxication: Restlessness, increased diuresis, muscle twitching

Withdrawal: lack of concentration, headache

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Nicotine

A

Intoxication: Restlessness

Withdrawal: irritability, anxiety, craving, increased appetite, dysphoria

CYP 450 inducer

Treatment: nicotine patch, gum, or lozenges
Buproprion/varenicline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Venlafaxine

A

SNRI
MOA: inhibit 5-HT and NE reuptake

Clinical: depression, generalized anxiety and panic disorders, fibromylagia, diabetic neuropathy, female stress incontinence
Depression WITH PAIN

Toxicity: increase BP, stimulant effects, sedation, nausea, vomiting, diarrhea, increased intraocular pressure

Withdrawal effects: flu, electric shocks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Methadone

A

MOA: LONG ACTING oral opiate, mu receptor agonist

Used for heroin detoxification to suppress withdrawal symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Fluphenazine

A

MOA: block dopamine receptors (increase cAMP)
High potency
Can be given in bi-monthly injection

Clinical: Schizophrenia positive symptoms, psychosis, acute mania, AND HUNTINGTONS

Toxicity: EPS-acute dystonia (sustained muscle contractions), akathisia (restlessness-treat with Beta blockers), Parkinsonism (tremor rigidity, bradykinesia-treat with anticholinergics (benztropine or diphenyhydramine) , increased LFTs, seizures

galactorrhea

Neuroleptic malignant syndrome: rigidity, myoglobinuria, autonomic instability, hyperpyrexia,
Treat with dantrolene, D2 agonists (brmocriptine)

Tardive dyskinesia: sterotpic oral-facial movements, lip smacking, chroathetoid movements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Alcohol

A

Intoxication: emotional liability, slurred speech, ataxia, coma, blackouts,
Serum y-glutamyltransfersase-sensitive indicator of alcohol use
Lab AST value is 2x ALT value
Chronic: Down regulates GABA receptors, up regulates NMDA receptors

Withdrawal:
Mild-symptoms similar to other depressants
Severe alcohol withdrawal can cause autonomic hyperactivity (increased temp and RR, insomnia) and Delirum tremens
Seziures, tachycardia, palpitatons
First manifestation is the shakes (tremors)

Treatment for Delirum tremens: benzodiazepines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Marijuana (cannabinoid)

A

MOA: Active ingredient in THC which stimulates canniboid receptors CB1 and CB2

Intoxication: euphoria, paranoid delusions, perception of slowed time, slowed reflexes, impaired judgement, social withdrawal, increased appetite, dry mouth, conjunctival injection, rapid heart rate, hallucinatons, short term memory loss

Prescription: dronabinol uses as antiemetic in chemo and appetite stimulant in AIDS

Withdrawal: irritability, depression, insomnia, nausea, anorexia
Symptoms peak in 48 hours
detectable in urine for 4-10 days but up to 30
stored in lipophilic tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Naloxone + buprenorphine

A

MOA: partial agonist
Long acting with fewer withdrawal symptoms than methadone

Naloxone not active if taken orally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Quetiapine

A

Atypical antipsychotic

MOA: Dopamine and sertonin antagonist

Clinical: schizophrenia positive and negative symptoms
MDD, PTSD

Toxicity: Least likely extrapyramidal, less anticholinergic side effects than traditional antipsychotics

increase glucose, lipids, weight gain, orthostasis, esophageal dysmotility,

SEDATING, CATARACTS, PARKINSON’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

PCP (phencyclidine)

A

MOA: antagnozies NMDA receptors

Intoxication: belligerence, impulsivness, fever, psychomotor agitation, analgesia, vertical and horizontal nystagmus, tachycardia, homicidality, ataxia, psychosis, delirium, seizures
Death due to trauma

Treatment: benzodiazpeines, rapid-acting antipsychotic

Withdrawal: depression, anxiety, irritability, restlessness, anergia (lack of energy), distrubances of thought and sleep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Naltrexone

A

Long acting opioid antagnosist used for relapse prevention once detoxified

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Haloperidol

A

MOA: block dopamine receptors (increase cAMP)
High potency

Clinical: Schizophrenia positive symptoms, psychosis, acute mania, acute psychosis, Tourette syndrome AND HUNTINGTONS

Toxicity: EPS-acute dystonia (sustained muscle contractions), akathisia (restlessness-treat with Beta blockers), Parkinsonism (tremor rigidity, bradykinesia-treat with anticholinergics (benztropine or diphenyhydramine) , increased LFTs, seizures

galactorrhea

Neuroleptic malignant syndrome: rigidity, myoglobinuria, autonomic instability, hyperpyrexia,
Treat with dantrolene, D2 agonists (brmocriptine)

Tardive dyskinesia: sterotpic oral-facial movements, lip smacking, chroathetoid movements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Thioridazine

A

MOA: block dopamine receptors (increase cAMP)
Low potency

Clinical: Schizophrenia positive symptoms, psychosis, acute mania, AND HUNTINGTONS

Toxicity: EPS-acute dystonia (sustained muscle contractions), akathisia (restlessness-treat with Beta blockers), Parkinsonism (tremor rigidity, bradykinesia-treat with anticholinergics (benztropine or diphenyhydramine) , increased LFTs, seizures

galactorrhea

Neuroleptic malignant syndrome: rigidity, myoglobinuria, autonomic instability, hyperpyrexia,
Treat with dantrolene, D2 agonists (brmocriptine)

Tardive dyskinesia: sterotpic oral-facial movements, lip smacking, chroathetoid movements

RETINAL DEPOSITS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mirtazapine

A

Atypical antidepressant

MOA: alpha2 antagonist (increases release of NE and 5HT) and potent 5HT2 and 5HT3 receptor antagonist

Toxicity: sedation (insomnia patients), increased appetite, weight gain (elderly, cancer or anorexic patients), dry mouth, agranulocytosis

Use in elderly

NO sexual and little GI side effects!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Olanzapine

A

Atypical antipsychotic

MOA: Dopmain and sertonin antagonist

Clinical: Schizophrenia positive and negative symptoms
Bipolar disorder,

Toxicity: Fewer EPS and anticholinergic side effects than traditional antipsychotics
Orthostasis, esophageal dysmotility

Weight gain-increased lipids and LFTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Fluoxetine (Prozac)

A

MOA:Serotonin reuptake inhibitors
Take 4-8 weeks to have an effect use BDZs temporarily

Used commonly due to low incidence of side effects which resolve with time, no food restrictions, much safer in overdose

CYP450 inhibitor
Longest half life-no need to taper

Safe in pregnancy and with children

Clinical: depression, generalized anxiety disorder, panic disorder, OCD, bulimia, social phobias, PTSD, IBS, migraines, autsim

Toxicity: Fewer side effects than TCAs
GI distress, sexual dysfunction, serotonin syndrome, nausea, diarrhea, anxiety, weight loss, insomnia (vivid dreams), headaches, restlessness, seizures (low risk)
can elevate levels of neuroleptics increasing side effects

Can cause weight loss

Watch with cough supprsesant for serotonin syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Aripiprazole

A

Atypical antipsychotic

MOA: dopamine and serotonin antagonist, partial dopamine agonist

Clinical: schizophrenia positive and negative symptoms
Bipolar disorder, OCD, anxiety disorder, depression, mania, Tourette syndrome

Toxicity: fewer EPS and anticholinergic side effects than traditional antipsychotcs
incresaed glucose, lipids, weight, orthostatsis, esophageal dysmotility

SEIZURES, MANIA, AKATHESIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Serotonin syndrome

A

Occurs with any drug that increases serotonin
Linezolid, TCAs, MAO inhibitors, SNRIs, triptans, tramadol, SSRIs

Symptoms: hyperthermia confusion, myoclonus, cardiovascular collapse, tachycardia, flushing, diarrhea, seizures, diaphoresis, rhabdomyolysis, renal failure, and death

Treatment: cyproheptadine (5HT Receptor antagonist) and stop medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Modafinil

A

Non amphetamine stimulant

1st line for narcolepsy

CYP-450 inducer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Amphetamines

A

Intoxication: euphoria, grandiosity, pupillary dilation, prolonged wakefulness and attention, hypertension, tachycardia, anorexia, paranoia,fever, diaphroresis, choreiform movements, tooth decay

Severe: cardiac arrest, seizure

Withdrawal: anhedonia (can’t experience pleasure from activities), increased appetite, hypersomnolence, existential crisis (question life)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Buspirone

A

MOA: stimulates 5-HT receptors

Clinical: generalized anxiety disorder
Does not cause sedation, addiction or tolerance
Does not interact with alcohol-useful in abuse patients

Takes 1-2 weeks to take effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Lithium

A

MOA: not established

Clinical: mood stabilizer for bipolar disorder, blocks relapse and acute manic events, SIADH, Alcohol dependency, aggression

Toxicity: tremor, sedation, edema, heart block, ataxia, delirium, hypothyroidism, polyuria, n/v, slurred speech, hyperreflexia, metal taste, weight gain, seizures

CAN CAUSE NEPHRONGENIC DIABETES INSIPIDUS

Ebstein anomaly and malformation of great vessels

Thiazide diuretics, ACE inhibitors and NSAIDS increase lithium levels

MNOP: movement (tremor), nephrogenic diabetes insipidus, hypOthyroidism, Pregnancy probs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Methylphenidate, dextroampheatmine, metamphetamine, phentermine
MOA: increase catecholamines at the synaptic cleft, especially NE and dopamine Treat: ADHD, narcolepsy, appetite control
25
Buproprion
Atypical antidperessant MOA: increase NE and dopamine by inhibiting presynpatic uptake Clinical: atypical depression and smoking cessation, migraines, depression in bipolar, adult ADHD Toxicity: stimulant effects (tacchycardia, insomnia), headache, nausea DON'T USE IN PATIENTS WITH EATING DISORDERS, EPILEPSY, OR ALCOHOL ABUSE DUE TO INCREASE RISK OF SEIZURES and psychosis or on MAOI No sexual side effects!!!
26
Trazodone
MOA: blocks 5Ht2 and alpha1 adrenergic receptors Clinical: primarily insomnia, high doses needed for antidepressant Toxicity: sedation, nausea, priapism (constant boner), postural hypotension, hepatotoxicity, dizziness, orthostatsis, cardiac arrhythmias
27
Ziprasidone
Atypical antipsychotic- MOA: Dopamine and serotonin antagonist Clinical: Schizophrenia positive and negative symptoms, Bipolar disorder, OCD, anxiety disorder, depression, mania, Tourette syndrome Toxicity: fewer EPS and anticholinergic side effects than traditional antipsychotics May prolong QT interval should obtain ECGs Less metabolic side effects
28
Akathisia
reslessnes and agiation Treatment: B-Blocker
29
Cocaine
MOA: Blocks reuptake of monoamines Intoxication: impaired judgement, pupillary dilation, hallucinations, paranoid ideations, angina, sudden cardiac death (coronary artery vasospasm), stroke, intracranial hemorrhage, seizures, sympathetic stimulation-tachycardia Treatment: benzodiazepines Withdrawal: hypersomonlence, malaise, severe psychological craving, depression/suicidality, increased appetite, psychomotor retardation, MI (increased demand and decreased perfusion)
30
Resperidone
Atypical antipsychotic MOA: Dopamine and Serotonin antagonists Fast acting Clinical: Schizophrenia positive and negative symptoms Bipolar disorder OCD, anxiety disorder, depression, mania, Tourette syndrome/tics toxicity: fewer EPS and anticholinergic side effects than traditional antipsychotics (however most likely atypical antipsychotic to cause EPS) Increases prolactin leading to lactation and gynecomastia Decreases GnRH, LH and FSH causing irregular menstruation and fertility issues
31
Varenicline
MOA: reinforces effects of nicotine that lead to dependene through partial agonistic acitivity on a4B2 nicotinic acetylcholin recpetor in CNS Decreases symptoms of withdrawal and attenuating rewards
32
Clozapine
Atypical antipsychotics MOA: Dopamine and serotonin antagonist Acts on D4 receptors Clinical: schizophrenia positive and negative symptoms (treatment resistant Schizo) Toxicity: NO EPS and anticholinergic side effects than traditional antipsychotics (least likely atypical antipsychotic to cause EPS) weight gain AGRANULOCYTOSIS-requires weekly WBC monitoring Seizures MYOCARDITIS
33
LSD (Lysergic Acid Diethylamide)
Intoxication: perceptual distortion (visual auditory), visual hallucinations, depersonalization, anxiety, paranoia, psychosis, possible flashback
34
Phenelzine
MOA: Increase levels of amine NTs-NE, 5HT, and dopamine Takes 2 weeks to re synthesize MAO- watch for serotonin syndrome-wait two weeks to switch to (fluoxetine 5 weeks), 2 weeks to come off Clinical: atypical depression, anxiety, hypochondriasis Toxicity: hypertensive crisis (ingestion of tyramine-wine and cheese), CNS stimulation, edema, orthostasis, weight gain, sexual, headache Treat with phentolamine Contraindicated: SSRIs, TCAs, St. John's wort, meperidine, and dextromehtorphan-prevents serotonin syndrome
35
Barbituates
intoxication: Low safety margin, marked respiratory depression CYP450 Inducers Treatment: symptom management-assist respiration, increase BP Withdrawal: delirium, life threatening cardiovascular collapse
36
Electro convulsive therapy
Produced painless seizure in anesthetized patient Treatment for major depressive disorder refractory to other treatments or pregnant women with depression Or when immediate response is necessary (suicide) Depression with psychotic features and Catatonia are also indications AE: disorientation, temporary headache, and partial anterograde/retrograde amnesia fully resolving in 6 months
37
Psychoanalysis
Goal is to resolve unconscious conflicts by bringing repressed experiences and feelings into awareness Insight oriented Patients: under the age of 40, not psychotic, intelligent, in stable relationships and function daily Useful in: Cluster C, Anxiety Disorders, OCD, Problems coping with life events, anorexia nervosa, sexual disorders, dysthymic disorder Focus: unconscious conflicts cause symptoms, explore positive relationships, break down defense mechanisms , talk about problems
38
Behavioral Therapy
Helping patients change behaviors that contribute to their symptoms Extinguishes maladaptive behaviors by replacing htem with healthy alternatives Classical and operant conditioning flooding: phobic disorders Systemic desensitization: phobic disorders Aversion therapy: paraphilias, substance abuse Token economy: showering, shaving Biofeedback: migraines, agoraphobia, fecal incontinence, tension headache, asthma, hypertension, chronic pain
39
Fluvoxamine (Luvox)
MOA:Serotonin reuptake inhibitors CYP450 inhibitor Lots of drug interactions Clinical: ONLY OCD Toxicity: Nausea and vomiting more common GI distress, sexual dysfunction, serotonin syndrome, nausea, diarrhea, anxiety, insomnia (vivid dreams), headaches, restlessness, seizures (low risk) can elevate levels of neuroleptics increasing side effects Watch with cough supprsesant for sserotonin syndrome
40
Cognitive Behavioral Therapy
Combines cognitive therapy and behavior therapy patient learns how behaviors is influenced by thoughts used in: depression, anxiety, and substance abuse
41
Hyperprolactinemia
Seen with high potency traditional anti-psychotics (haloperidol and trifluoperazine) and risperidone
42
Hypertensive Crisis
Caused by builldup of stored catecholamines (NE) MAOIs + foods with tyramine (red wine, cheese, chicken liver, cured meats) or plus sympathomimetics Treat with: Phentolamine
42
Dystonia
Sustained contraction of muscles of neck, tongue, eyes, diaphragm within days High potency traditional antipsychotics (haloperidol and trifluoperazine) Treat with: benedryl/cogentin
43
Group Therapy
Patients with similar problem or pathology meet together with a therapist for group sessions Treat: substance abuse, adjustment disorder, eating disorder and personality disorders Advantages: patients get immediate feedback and support from peers and may gain insight Universilization: patient is not alone in their suffering Group cohesion: group working towards same goal
44
Parkinsonism
Masklike face, cogwheel rigidiity, pill rolling tremor Occur with high potency traditonal antipsychotics (haloperidiol and trifluoperazine) Happens within months Treat with benztropine
45
Cognitive Therapy
Corrects faulty assumptions and negative feelings that exacerbate psychiatric symptoms Treats: depression and anxiety paranoid personality disorder, OCD, somatoform disorder, and eating disorders
46
Tardive Dyskinesia
Choreoatetoid muscle movements usually of mouth and tongue Occur after years of antipsychotic use particularly high potency traditional antipsychotics (haloperidol, trifluoperazine) Can be irreversible Treat with benztropine
47
Neuroleptic maligant syndrome
Fever, tachycardia, hypertension, tremor, elevated CPK, lead pipe rigidity, leukocytosis, Can be caused by all antipsychotics after short or long time (increased risk with high potency traditional antipsychotics-haloperidol and trifluoperazine) Treatment: stop drug, benedryl, dantrolene/bromocriptine/amantadine
49
Amitriptyline
MOA: block reuptake of NE and 5HT Also block Na channels, Ach channels, alpha adrenergic, block histamine Clinical: major depression, fibromyalgia, painful diabetic neuropahty (insomnia with depression) also for pain Toxicity: Sedation alpha blocking: postural hypotension Anticholinergic: dry mouth, tachycardia, urinary retention, Confusion and hallucinations in elderly, hyperthermia, dilated pupils Na block: cardiotoxcity leads to death treat with NaHCO3, QT prolongation and cardiac dysrhthymias NaHCO3 can correct QRS prolongation, reverse hypotension and treat ventricular dysrhthymias Tri-Cs: convulsion, coma, cardiotoxicity Respiratory depression, hyperpyrexia (high fever) CAUTION in BPH
50
Sertraline (Zoloft)
MOA:Serotonin reuptake inhibitors Used commonly due to low incidence of side effects which resolve with time, no food restrictions, much safer in overdose CYP450 inhibitor Clinical: depression, generalized anxiety disorder, panic disorder, OCD, bulimia, social phobias, PTSD, IBS, migraines, autsim Toxicity: Fewer side effects than TCAs highest risk of GI distress (N/V/D), sedation sexual dysfunction, serotonin syndrome, nausea, diarrhea, anxiety, weight loss, insomnia (vivid dreams), headaches, restlessness, seizures (low risk) can elevate levels of neuroleptics increasing side effects Watch with cough supprsesant for sserotonin syndrome
51
Withdrawal phenomenom of antidpressants
dizziness, headaches, nausea, insomnia and malaise May need to be tapered
52
Paroxetine (Paxil)
MOA:Serotonin reuptake inhibitors-stimulant Used commonly due to low incidence of side effects which resolve with time, no food restrictions, much safer in overdose CYP450 inhibitor Short half life can lead to withdrawal phenomena Clinical: depression, generalized anxiety disorder, panic disorder, OCD, bulimia, social phobias, PTSD, IBS, migraines, autsim Toxicity: Fewer side effects than TCAs GI distress, sexual dysfunction, serotonin syndrome, nausea, diarrhea, anxiety, More anticholinergic SE: sedation, constipation, weight gain, headaches, restlessness, seizures (low risk) can elevate levels of neuroleptics increasing side effects Worse for sexual sdie efects and weight gain Late night sedation Several Drug interactions Watch with cough supprsesant for sserotonin syndrome
54
Dialectical Behavior Thearpy
Diminishes self destructive behaviors and hospitalizations Incorporates cognitive and supportive techniques, improve emotion and regulation, distress tolerance, mindful awareness Treats: Borderline personality disorder, self injury
54
Citalopram (Celexa)
MOA:Serotonin reuptake inhibitors Used commonly due to low incidence of side effects which resolve with time, no food restrictions, much safer in overdose Clinical: depression, generalized anxiety disorder, panic disorder, OCD, bulimia, social phobias, PTSD, IBS, migraines, autsim Toxicity: Fewer side effects than TCAs LEAST Sexual side effects GI distress, sexual dysfunction, serotonin syndrome, nausea, diarrhea, anxiety, insomnia (vivid dreams), headaches, restlessness, seizures (low risk) can elevate levels of neuroleptics increasing side effects Can increase QTc interveal FEWEST Drug interactions Watch with cough supprsesant for sserotonin syndrome
55
Desvenlafaxine
SNRI MOA: inhibit 5-HT and NE reuptake Clinical: depression, generalized anxiety and panic disorders, fibromylagia, diabetic neuropathy, female stress incontinence Depression WITH PAIN Toxicity: increase BP, stimulant effects, sedation, nausea, vomiting, diarrhea
56
Duloxetine
SNRI MOA: inhibit 5-HT and NE reuptake Clinical: depression, generalized anxiety and panic disorders, fibromylagia, diabetic neuropathy, female stress incontinence Depression WITH PAIN Toxicity: increase BP, stimulant effects, sedation, nausea, vomiting, diarrhea, hepatatoxicity, bleeding
57
Milnacipran
SNRI MOA: inhibit 5-HT and NE reuptake Clinical: Only fibromyalgia Toxicity: increase BP, stimulant effects, sedation, nausea, vomiting, diarrhea
58
Nefazodone
MOA: blocks 5Ht2 and alpha1 adrenergic receptors Clinical: primarily insomnia, high doses needed for antidepressant Toxicity: sedation, nausea, postural hypotension, hepatotoxicity, dizziness, orthostatsis Liver failure-black box warning
60
Levomilnacipran
SNRI MOA: inhibit 5-HT and NE reuptake Clinical: depression with pain Toxicity: increase BP, stimulant effects, sedation, nausea, vomiting, diarrhea
60
Clomipramine
MOA: block reuptake of NE and 5HT Also block Na channels, Ach channels, alpha adrenergic, block histamine Clinical: major depression, fibromyalgia, painful diabetic neuropahty (insomnia with depression) OCD-clomipramine Toxicity: Sedation alpha blocking: postural hypotension Anticholinergic: dry mouth, tachycardia, urinary retention, Confusion and hallucinations in elderly, hyperthermia, dilated pupils Na block: cardiotoxcity leads to death treat with NaHCO3, QRS prolongation and cardiac dysrhthymias NaHCO3 can correct QRS prolongation, reverse hypotension and treat ventricular dysrhthymias Tri-Cs: convulsion, coma, cardiotoxicity Respiratory depression, hyperpyrexia (high fever) CAUTION in BPH
61
Escitalopram (Lexapro)
MOA:Serotonin reuptake inhibitors Much like citalopram but more expensive! Used commonly due to low incidence of side effects which resolve with time, no food restrictions, much safer in overdose Clinical: depression, generalized anxiety disorder, panic disorder, OCD, bulimia, social phobias, PTSD, IBS, migraines, autsim Toxicity: Fewer side effects than TCAs LEAST Sexual side effects GI distress, sexual dysfunction, serotonin syndrome, nausea, diarrhea, anxiety, insomnia (vivid dreams), headaches, restlessness, seizures (low risk) can elevate levels of neuroleptics increasing side effects Fewest Drug interactions Watch with cough supprsesant for sserotonin syndrome
62
Imipramine
MOA: block reuptake of NE and 5HT Also block Na channels, Ach channels, alpha adrenergic, block histamine Clinical: major depression, fibromyalgia, painful diabetic neuropahty (insomnia with depression) also enuresis and pain Toxicity: Sedation alpha blocking: postural hypotension Anticholinergic: dry mouth, tachycardia, urinary retention, Confusion and hallucinations in elderly, hyperthermia, dilated pupils Na block: cardiotoxcity leads to death treat with NaHCO3, QT prolongation and cardiac dysrhthymias NaHCO3 can correct QRS prolongation, reverse hypotension and treat ventricular dysrhthymias Tri-Cs: convulsion, coma, cardiotoxicity Respiratory depression, hyperpyrexia (high fever) CAUTION in BPH
63
Nortriptyline
MOA: block reuptake of NE and 5HT Also block Na channels, Ach channels, alpha adrenergic, block histamine Clinical: major depression, fibromyalgia, painful diabetic neuropahty (insomnia with depression) Also for enuresis Toxicity: Sedation alpha blocking: postural hypotension Anticholinergic: dry mouth, tachycardia, urinary retention, Confusion and hallucinations in elderly, hyperthermia, dilated pupils Na block: cardiotoxcity leads to death treat with NaHCO3, QT prolongation and cardiac dysrhthymias NaHCO3 can correct QRS prolongation, reverse hypotension and treat ventricular dysrhthymias Tri-Cs: convulsion, coma, cardiotoxicity Respiratory depression, hyperpyrexia (high fever) CAUTION in BPH
63
Doxepin
MOA: block reuptake of NE and 5HT Also block Na channels, Ach channels, alpha adrenergic, block histamine Clinical: major depression, fibromyalgia, painful diabetic neuropahty (insomnia with depression) Toxicity: Sedation alpha blocking: postural hypotension Anticholinergic: dry mouth, tachycardia, urinary retention, Confusion and hallucinations in elderly, hyperthermia, dilated pupils Na block: cardiotoxcity leads to death treat with NaHCO3, QT prolongation and cardiac dysrhthymias NaHCO3 can correct QRS prolongation, reverse hypotension and treat ventricular dysrhthymias Tri-Cs: convulsion, coma, cardiotoxicity Respiratory depression, hyperpyrexia (high fever) CAUTION in BPH
64
Trimipramine
MOA: block reuptake of NE and 5HT Also block Na channels, Ach channels, alpha adrenergic, block histamine Clinical: major depression, fibromyalgia, painful diabetic neuropahty (insomnia with depression) Toxicity: Sedation alpha blocking: postural hypotension Anticholinergic: dry mouth, tachycardia, urinary retention, Confusion and hallucinations in elderly, hyperthermia, dilated pupils Na block: cardiotoxcity leads to death treat with NaHCO3, QT prolongation and cardiac dysrhthymias NaHCO3 can correct QRS prolongation, reverse hypotension and treat ventricular dysrhthymias Tri-Cs: convulsion, coma, cardiotoxicity Respiratory depression, hyperpyrexia (high fever) CAUTION in BPH
65
Isocarboxazid
MOA: Increase levels of amine NTs-NE, 5HT, and dopamine Takes 2 weeks to re synthesize MAO- watch for serotonin syndrome-wait two weeks to switch to (fluoxetine 5 weeks), 2 weeks to come off Clinical: atypical depression, anxiety, hypochondriasis Toxicity: hypertensive crisis (ingestion of tyramine-wine and cheese), CNS stimulation, edema, orthostasis, weight gain, sexual, headache Treat with phentolamine Contraindicated: SSRIs, TCAs, St. John's wort, meperidine, and dextromehtorphan-prevents serotonin syndrome
67
Tranylcypromine
MOA: Increase levels of amine NTs-NE, 5HT, and dopamine Takes 2 weeks to re synthesize MAO- watch for serotonin syndrome-wait two weeks to switch to (fluoxetine 5 weeks), 2 weeks to come off Clinical: atypical depression, anxiety, hypochondriasis Toxicity: hypertensive crisis (ingestion of tyramine-wine and cheese), CNS stimulation, edema, orthostasis, weight gain, sexual, headache Treat with phentolamine Contraindicated: SSRIs, TCAs, St. John's wort, meperidine, and dextromehtorphan-prevents serotonin syndrome
68
Clonazepam
MOA: increases GABA by increasing frequency of Cl- channel opening Intermediate acting Uses: seizures, insomnia, GAD, Alcohol withdrawal PANIC ATTACKS Lethal with alcohol Toxicity: dependence, additive CNS depression with alcohol, less respiratory depression and coma than barbiturates, sedation impairs coordination and balance (avoid in elderly), decreased memory and concentration LESS DROWSINESS SEVERE WITHDRAWAL SYMPTOMS AND HIGHER ADDICTIVE POTENTIAL Treat overdose with flumazenil (competitive antagonist at GABA benzodiazepine receptor)
69
Clonidine
a2 agonists | Used for opioid detoxification, tourrettes/tics
70
Propanolol
Used for panic attacks, social phobia, akathesia | Helps with sweating and tachycardia
71
Donepezil
Cholinesterase inhibitor | slows progression of Alzheimers
72
Zolpidem
For sleep Not a BDZ But binds to same receptor No addiction and no withdrawal
74
Alprazolam
MOA: increases GABA by increasing frequency of Cl- channel opening Short acting Uses: seizures, insomnia, GAD, Alcohol withdrawal PANIC ATTACKS Lethal with alcohol Toxicity: dependence, additive CNS depression with alcohol, less respiratory depression and coma than barbiturates, sedation impairs coordination and balance (avoid in elderly), decreased memory and concentration LESS DROWSINESS SEVERE WITHDRAWAL SYMPTOMS AND HIGHER ADDICTIVE POTENTIAL Treat overdose with flumazenil (competitive antagonist at GABA benzodiazepine receptor)
75
Interpersonal Therapy
For: relationship conflicts, life role transitions, grief Focus current relationships and conflicts
76
memantine
NMDA antagonist | Used in alzheimers
77
Perphenazine
MOA: block dopamine receptors (increase cAMP) Low potency Clinical: Schizophrenia positive symptoms, psychosis, acute mania, AND HUNTINGTONS Toxicity: EPS-acute dystonia (sustained muscle contractions), akathisia (restlessness-treat with Beta blockers), Parkinsonism (tremor rigidity, bradykinesia-treat with anticholinergics (benztropine or diphenyhydramine) , increased LFTs, seizures galactorrhea Neuroleptic malignant syndrome: rigidity, myoglobinuria, autonomic instability, hyperpyrexia, Treat with dantrolene, D2 agonists (brmocriptine) Tardive dyskinesia: sterotpic oral-facial movements, lip smacking, chroathetoid movements
78
Chlropromazine
MOA: block dopamine receptors (increase cAMP) Low potency Clinical: Schizophrenia positive symptoms, psychosis, acute mania, AND HUNTINGTONS Toxicity: EPS-acute dystonia (sustained muscle contractions), akathisia (restlessness-treat with Beta blockers), Parkinsonism (tremor rigidity, bradykinesia-treat with anticholinergics (benztropine or diphenyhydramine) , increased LFTs, seizures BLUE SKIN, CORNEAL DEPOSITS galactorrhea Neuroleptic malignant syndrome: rigidity, myoglobinuria, autonomic instability, hyperpyrexia, Treat with dantrolene, D2 agonists (brmocriptine) Tardive dyskinesia: sterotpic oral-facial movements, lip smacking, chroathetoid movements
79
Lorazepam
MOA: Facilitate GABA by increasing frequency of Cl- channel opening Decreases REM sleep Clinical: anxiety, spasticity, status epilepticus (diazepam), detoxification from alcohol delirum tremens, general anesthetic (amnesia muscle relaxation), hypnotic (insomnia) GOOD FOR ALCOHOL WITHDRAWAL, PRESURGERY ANXIETY Diazepam and chlrodizepoxide are first line treatment for seizures assoicated with alcohol withdrawal Toxicity: Less dependence (due to slower clearance), Higher daytime drowsiness (increased chance of falls), additive CNS ddepression effects with alcohol, less risk of respiratory depression and coma than barbiturates, sedation impairs coordination and balance (avoid in elderly) decreased memory and concentration Avoid with alcohol, barbituates, neuroleptics and 1st gen antihistamines Treat overdose with flumazenil (competitive antagonist at GABA benzodiazepine receptor)
80
Supportive therapy
For: lower functioning patient, psychotic, cognitively impaired, acute life crisis Focus: reinforce coping skills, build up adaptive defense mechanisms
81
Carbamazepine
blocks Na-voltage gated channels, increases GABA used for bipolar rapid cycling, mixed episodes Side effects: increased LFTs, teratogenic, hyponatremia, aplastic anemia
82
Lamotrigine
No acute use, used for mood stabilization Side effects: rash, cytopenias, multi-organ hypersensivity
83
Oxazepam
MOA: increases GABA by increasing frequency of Cl- channel opening Short acting Uses: seizures, insomnia, GAD, Alcohol withdrawal Lethal with alcohol Toxicity: dependence, additive CNS depression with alcohol, less respiratory depression and coma than barbiturates, sedation impairs coordination and balance (avoid in elderly), decreased memory and concentration LESS DROWSINESS SEVERE WITHDRAWAL SYMPTOMS AND HIGHER ADDICTIVE POTENTIAL Treat overdose with flumazenil (competitive antagonist at GABA benzodiazepine receptor)
84
Triazolam
MOA: increases GABA by increasing frequency of Cl- channel opening Short acting Uses: seizures, GAD, Alcohol withdrawal INSOMNIA Lethal with alcohol Toxicity: dependence, additive CNS depression with alcohol, less respiratory depression and coma than barbiturates, sedation impairs coordination and balance (avoid in elderly), decreased memory and concentration LESS DROWSINESS SEVERE WITHDRAWAL SYMPTOMS AND HIGHER ADDICTIVE POTENTIAL Treat overdose with flumazenil (competitive antagonist at GABA benzodiazepine receptor)
85
Chlrodiazepam
MOA: Facilitate GABA by increasing frequency of Cl- channel opening Decreases REM sleep Clinical: anxiety, spasticity, status epilepticus (diazepam), detoxification from alcohol delirum tremens, general anesthetic (amnesia muscle relaxation), hypnotic (insomnia) GOOD FOR ALCOHOL WITHDRAWAL, PRESURGERY ANXIETY Diazepam and chlrodizepoxide are first line treatment for seizures assoicated with alcohol withdrawal Toxicity: Less dependence (due to slower clearance), Higher daytime drowsiness (increased chance of falls), additive CNS ddepression effects with alcohol, less risk of respiratory depression and coma than barbiturates, sedation impairs coordination and balance (avoid in elderly) decreased memory and concentration Avoid with alcohol, barbituates, neuroleptics and 1st gen antihistamines Treat overdose with flumazenil (competitive antagonist at GABA benzodiazepine receptor)
86
Valproic Acid
Increases GABA Used: bipolar disorder, alcohol dependenc, psychosis, agression, rapid cycling bipolar Side effects: teratogenic, hepatotoxic, thrombocytopenia, nausea, sedation, alopecia, pancreatitis
86
Diazepam
MOA: Facilitate GABA by increasing frequency of Cl- channel opening Decreases REM sleep Clinical: anxiety, spasticity, status epilepticus (diazepam), detoxification from alcohol delirum tremens, general anesthetic (amnesia muscle relaxation), hypnotic (insomnia) Diazepam and chlrodizepoxide are first line treatment for seizures assoicated with alcohol withdrawal Toxicity: Less dependence (due to slower clearance), Higher daytime drowsiness (increased chance of falls), additive CNS ddepression effects with alcohol, less risk of respiratory depression and coma than barbiturates, sedation impairs coordination and balance (avoid in elderly) decreased memory and concentration Avoid with alcohol, barbituates, neuroleptics and 1st gen antihistamines Treat overdose with flumazenil (competitive antagonist at GABA benzodiazepine receptor)
87
Tacrine
Cholinesterase inhibitor | Slows progression of Alzheimers
88
Zaleplon
For sleep Not a BDZ But binds to same receptor No addiction and no withdrawal
88
Motivational therapy
Used in substance abuse Address ambivalence to change, non judgmental, enhance motivation to change
89
Temazepam
MOA: Facilitate GABA by increasing frequency of Cl- channel opening Decreases REM sleep Clinical: anxiety, spasticity, status epilepticus (diazepam), detoxification from alcohol delirum tremens, general anesthetic (amnesia muscle relaxation), hypnotic (insomnia) GOOD FOR ALCOHOL WITHDRAWAL, PRESURGERY ANXIETY Diazepam and chlrodizepoxide are first line treatment for seizures assoicated with alcohol withdrawal Toxicity: Less dependence (due to slower clearance), Higher daytime drowsiness (increased chance of falls), additive CNS ddepression effects with alcohol, less risk of respiratory depression and coma than barbiturates, sedation impairs coordination and balance (avoid in elderly) decreased memory and concentration Avoid with alcohol, barbituates, neuroleptics and 1st gen antihistamines Treat overdose with flumazenil (competitive antagonist at GABA benzodiazepine receptor)
91
Despramine
MOA: block reuptake of NE and 5HT Also block Na channels, Ach channels, alpha adrenergic, block histamine Clinical: major depression, fibromyalgia, painful diabetic neuropahty (insomnia with depression) LEAST SIDE EFFECTS, LEAST SEDATING Toxicity: Sedation alpha blocking: postural hypotension Anticholinergic: dry mouth, tachycardia, urinary retention, Confusion and hallucinations in elderly, hyperthermia, dilated pupils Na block: cardiotoxcity leads to death treat with NaHCO3, QT prolongation and cardiac dysrhthymias NaHCO3 can correct QRS prolongation, reverse hypotension and treat ventricular dysrhthymias Tri-Cs: convulsion, coma, cardiotoxicity Respiratory depression, hyperpyrexia (high fever) CAUTION in BPH
92
Biofeedback therapy
For: prominent physical symptoms that accompany psych symptoms Focus: improve awareness and control over physiological reactions Lower stress levels Integrate mind and body
93
Flurazepam
MOA: Facilitate GABA by increasing frequency of Cl- channel opening Decreases REM sleep Clinical: anxiety, spasticity, status epilepticus (diazepam), detoxification from alcohol delirum tremens, general anesthetic (amnesia muscle relaxation), hypnotic (insomnia) Diazepam and chlrodizepoxide are first line treatment for seizures assoicated with alcohol withdrawal Toxicity: Less dependence (due to slower clearance), Higher daytime drowsiness (increased chance of falls), additive CNS ddepression effects with alcohol, less risk of respiratory depression and coma than barbiturates, sedation impairs coordination and balance (avoid in elderly) decreased memory and concentration Avoid with alcohol, barbituates, neuroleptics and 1st gen antihistamines Treat overdose with flumazenil (competitive antagonist at GABA benzodiazepine receptor)